Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Res Social Adm Pharm. 2015 Jun 15;12(2):218–246. doi: 10.1016/j.sapharm.2015.06.001

Table 2.

Individual primary study information for treatment vs. control comparisons

Study & Location Sample Methods Intervention Effect Size
Alhalaiqa et al., 20129 Great Britain N: 136
Mean meds: 3.3
Health: 100% HTN
% female: 53.7
% non-Caucasian: NA
% MA criterion: NA
Randomized: Yes
Allocation concealed: Yes
Blinded: Yes
% Attrition: 0
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Pill counts
Theory: NA
Interventionist: NA
Content: Drug education, problem solving, thought restructuring
Target: Medication adherence (MA) only
Delivery: Face-to-face
Dose: 7 sessions, 20 min each
3.293
Austin, 198611 United States N: 30
Mean meds: 3.1
Health: 100% HTN, 30% diabetes, 13% cardiac, 10% kidney disease, 3% gallbladder disease, 10% stroke, 17% other
% female: 57
% non-Caucasian: 100
% MA criterion: 80
Randomized: Yes
Allocation concealed: NA
Blinded: No
% Attrition: 0
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: Social Cognitive Theory
Interventionist: Registered nurse
Content: Improve self-management skills, self-monitoring of MA and BP, feedback about MA and BP, habit linking, rewards, social support
Target: MA and additional health behaviors
Delivery: Face-to-face
Dose: 3 sessions, 45 min each
0.277
Burrelle, 198613 United States N: 16
Mean meds: 5.94
Health: 100% HTN
% female: 75
% non-Caucasian: 75
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 0
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Pill counts
Theory: NA
Interventionist: Nurse, pharmacist, social worker
Content: Medication-taking calendar, disease/drug education, pill boxes
Target: MA only
Delivery: Face-to-face, written materials
Dose: 1 session
2.303
Cook et al., 201014 United States N: 10
Mean meds: NA
Health: 100% glaucoma
% female: 42
% non-Caucasian: 58.3
% MA criterion: 80
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 16.7
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: Motivational interviewing
Interventionist: Person other than HCP
Content: Motivational interviewing, barriers management, problem solving education/counseling
Target: MA only materials, drug
Delivery: Face-to-face, telephone, written
Dose: 3 in-person sessions, 30–45 min each, 3 telephone contacts, 5–10 min each
1.295
De Geest et al., 200615 Switzerland N: 13
Mean meds: NA
Health: 100% kidney transplant
% female: 21.4
% non-Caucasian: NA
% MA criterion: 98
Randomized: Yes
Allocation concealed: Yes
Blinded: No
% Attrition: 28
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: NA
Interventionist: Nurse
Content: Drug education, monitoring MA by device with feedback about MA, goal setting, problem solving, habit linking, patient empowerment, self-efficacy enhancement, self-management education
Target: MA only
Delivery: Face-to-face, telephone
Dose: 4 sessions
0.047
Freedman, 200717 United States N: 16
Mean meds: NA
Health: 100% HIV
% female: 81.3
% non-Caucasian: 75
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 0
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: NA
Interventionist: NA
Content: Disease/drug education, improve patient communication with provider, goal setting, problem solving, stress management, investigator-formed support group
Target: MA and additional health behaviors
Delivery: Face-to-face, written materials
Dose: 8 sessions, 90 min each
0.386
Gamble et al., 201118 Ireland N: 18
Mean meds: NA
Health: 100% asthma
% female: 85
% non-Caucasian: NA
% MA criterion: 50
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 10
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Prescription refills
Theory: Cognitive-behavioral Theory, motivational interviewing, Transtheoretical Stages of Change Model
Interventionist: Nurse
Content: Motivational interviewing, behavior modification, disease/drug education
Target: MA only
Delivery: Face-to-face
Dose: 8 sessions
1.431
Glanz et al., 201219 United States N: 246
Mean meds: NA
Health: 100% glaucoma
% female: 37.5
% non-Caucasian: 90.7
% MA criterion: NA
Randomized: No
Allocation concealed: No
Blinded: No
% Attrition: 5
ITT: NA
Comparison: True control
Tx fidelity: NA
MA Measure: Prescription refills
Theory: NA
Interventionist: Automated delivery
Content: Disease/drug education, barriers management, problem solving
Target: MA only
Delivery: Telephone, mail
Dose: 12 phone calls, 12 mailings
−0.031
Harper, 198421 United States N: 59
Mean meds: 5.25
Health: 100% HTN, 70% osteoarthritis, 55% cardiac disease, 45% diabetes
% female: 100
% non-Caucasian: 100
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 1.7
ITT: NA
Comparison: True control
Tx fidelity: NA
MA Measure: Pill counts
Theory: Orem’s Self-care Theory, General System Theory
Interventionist: Nurse
Content: Drug education, rewards, habit linking, cues/prompts, special labelling, side effects management
Target: MA and additional health behaviors
Delivery: Face-to-face
Dose: 4 sessions
1.047
Haynes et al., 197622 Canada N: 38
Mean meds: NA
Health: 100% HTN, mean 3.4 other chronic illnesses
% female: 0
% non-Caucasian: NA
% MA criterion: 80
Randomized: Yes
Allocation concealed: No
Blinded: Yes
% Attrition: 2.6
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Pill count
Theory: NA
Interventionist: Person other than HCP
Content: Drug reminder chart, habit linking, self-monitoring of medication taking, symptoms, cues/prompts
Target: MA and additional health behaviors
Delivery: Face-to-face
Dose: 13 sessions, 30 min each
0.569
Kalichman et al., 201125 United States N: 39
Mean meds: NA
Health: 100% HIV
% female: 35.0
% non-Caucasian: 92.5
% MA criterion: 95
Randomized: Yes
Allocation concealed: Yes
Blinded: Yes
% Attrition: 2.5
ITT: Yes
Comparison: Attention control
Tx fidelity: 99%
MA Measure: Self-report
Theory: Self-regulation Theory, Self-management Theory
Interventionist: Person other than HCP
Content: Improve self-management skills, barriers management, goal setting, problem solving, pill boxes, cues/prompts, habit linking, disease/drug education, drug counseling, diary to self-monitor MA, feedback about MA
Target: MA only
Delivery: Face-to-face, telephone
Dose: 5 sessions
0.460
Kogos, 200426 United States N: 30
Mean meds: NA
Health: various unspecified chronic illnesses
% female: 0
% non-Caucasian: 27.0
% MA criterion: NA
Randomized: No
Allocation concealed: NA
Blinded: NA
% Attrition: 0
ITT: No
Comparison: Attention control
Tx fidelity: NA
MA Measure: Pill counts
Theory: Health Belief Model
Interventionist: Person other than HCP
Content: Barriers management, contracting, goal setting, problem solving, self-monitor medication taking, self-management education, intervention delivered in both group and individual contexts
Target: MA and additional health behaviors
Delivery: Face-to-face, written materials
Dose: 5 sessions, 60 min each
−0.312
Levensky, 200629 United States N: 53
Mean meds: NA
Health: 100% HIV
% female: 15
% non-Caucasian: 22
% MA criterion: 90
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 1.9
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Pill counts
Theory: Motivational interviewing, Theory, Problem-solving Theory Social Cognitive
Interventionist: Nurse, unspecified other HCP, person other than HCP
Content: Motivational interviewing, behavior modification, self-efficacy enhancement, contracting/commitment to increased MA, barriers management, problem solving, goal setting, rewards, pill boxes, habit linking, diary o self-monitor MA, disease/drug education, drug counseling, simplifying medication regimen, side effects management, improve patient communication with health care provider, teach provider skills to improve communication with patient and promote MA; improve integration of health care
Target: MA and additional health behaviors
Delivery: Face-to-face, telephone, written materials
Dose: 3–4 sessions depending on patient needs
0.393
Matteson, 201131 United States N: 5
Mean meds: NA
Health: 100% inflammatory bowel disease
% female: 42.1
% non-Caucasian: NA
% MA criterion: 85
Randomized: Yes
Allocation concealed: Yes
Blinded: NA
% Attrition: 0
ITT: No
Comparison: Attention control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: Continuous Self-improvement Framework
Interventionist: Advanced practice nurse
Content: Behavior modification, personal system change, habit linking, feedback about MA, drug education
Target: MA only
Delivery: Face-to-face
Dose: 1 session averaging 32.5 min
1.821
McPherson-Baker et al., 200032 United States N: 42
Mean meds: NA
Health: 100% HIV
% female: 0
% non-Caucasian: 88.1
% MA criterion: NA
Randomized: No
Allocation concealed: NA
Blinded: NA
% Attrition: 0
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Prescription refills
Theory: Health BeliefModel
Interventionist: Pharmacist
Content: Disease/drug education, barriers management, problem solving, behavior rehearsal, modeling medication-taking behaviors, improve self-management skills
Target: MA only
Delivery: Face-to-face
Dose: 5 sessions, 20–25 min each
1.475
Migneault et al., 201233 United States N: 337
Mean meds: 5.1
Health: 100% HTN, 37% diabetes, 7.7% history of stroke
% female: 70.4
% non-Caucasian: 100
% MA criterion: NA
Randomized: Yes
Allocation concealed: Yes
Blinded: No
% Attrition: 0
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: Motivational interviewing, Social Cognitive Theory, Transtheoretical Stages of Change Model
Interventionist: Automated delivery
Content: Motivational interviewing, drug education/counseling, self-monitoring of BP, feedback about MA
Target: MA and additional health behaviors
Delivery: Telephone
Dose: 8 contacts
0.233
Mitchell, 199334 United States N: 109
Mean meds: NA
Health: 100% HTN
% female: 61
% non-Caucasian: 5
% MA criterion: NA
Randomized: Yes
Allocation concealed: Yes
Blinded: NA
% Attrition: NA
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: self-report
Theory: Health Promotion Model, Social Cognitive Theory
Interventionist: Advanced practice nurse
Content: Self-efficacy enhancement, value clarification, goal setting, problem solving, barriers management, monitoring MA by device with feedback about MA
Target: MA and additional health behaviors
Delivery: Face-to-face, telephone
Dose: 4 sessions
−0.315
Moitra et al., 201135 United States N: 10
Mean meds: NA
Health: 100% HIV
% female: 7.7
% non-Caucasian: 84.6
% MA criterion: NA
Randomized: yes
Allocation concealed: NA
Blinded: NA
% Attrition: 67.7
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: Acceptance and Commitment Theory
Interventionist: Person other than HCP
Content: Acceptance and commitment therapy, goal setting, self-re-evaluation, disease/drug education, drug counseling, investigator-formed support group
Target: MA only
Delivery: Face-to-face, written materials
Dose: 4 sessions, 60 min each
0
Murphy et al., 200237 United States N: 33
Mean meds: NA
Health: 100% HIV
% female: 12.0
% non-Caucasian: 64
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 36.5
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: Cognitive-behavioral Theory, Social Cognitive Theory
Interventionist: Nurse, person other than HCP
Content: Behavior and cognitive modification, disease/drug education, cues/prompts, barriers management, goal setting, problem solving, relapse prevention, improve patient ability to communicate with provider, social support via experimenter-formed group
Target: MA and exercise
Delivery: Face-to-face, written materials
Dose: 5 sessions
0.795
Murphy et al., 200738 United States N: 141
Mean meds: NA
Health: 100% HIV
% female: 17.6
% non-Caucasian: 70.4
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: NA
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: Cognitive-behavioral Theory, Social Cognitive Theory
Interventionist: Nurse, person other than HCP
Content: Behavior and cognitive modification; disease education, cues/prompts, barriers management, problem solving, rewards, diary to self-monitor MA, improve patient ability to communicate with provider, social support via investigator-formed group
Target: MA only
Delivery: Face-to-face
Dose: 5 sessions, 90 min + 4 sessions, 60 min
0.249
Nietert et al., 200939 United States N: 2,032
Mean meds: NA
Health: 56.4% HTN or heart failure, 11.3% diabetes, 17.4% hyperlipidemia, 14.2% depression
% female: NA
% non-Caucasian: NA
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: No
% Attrition: 0
ITT: Yes
Comparison: NA
Tx fidelity: NA
MA Measure: Prescription refills
Theory: NA
Interventionist: Pharmacist, person other than HCP
Content: Drug education, telephone prompts to remind patient to refill prescriptions, barriers management, problem solving
Target: MA only
Delivery: Telephone
Dose: NA
−0.012
Nietert et al., 200939 United States N: 2,030
Mean meds: NA
Health: 56% HTN or heart failure, 11.3% diabetes, 17.3% hyperlipidemia, 14.9% depression
% female: NA
% non-Caucasian: NA
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: No
% Attrition: 0
ITT: Yes
Comparison: NA
Tx fidelity: NA
MA Measure: Prescription refills
Theory: NA
Interventionist: None
Content: Patient prescription refill information faxed to physician along with written prompts for physicians to encourage patients’ medication persistence
Target: MA only
Delivery: FAX sent to patients’ physicians
Dose: NA
−0.061
Okeke et al., 200941 United States N: 66
Mean meds: NA
Health: 100% glaucoma
% female: 45.5
% non-Caucasian: 62.1
% MA criterion: 75
Randomized: Yes
Allocation concealed: Yes
Blinded: NA
% Attrition: 0
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: NA
Interventionist: NA
Content: Disease/drug education, barriers self-management, problem solving, cues/prompts, habit linking, drug reminder chart, diary to monitor MA, social support
Target: MA only
Delivery: Face-to-face, telephone, video
Dose: 10 sessions
0.844
Oser, 200842 United States N: 22
Mean meds: NA
Health: 100% HTN
% female: 0
% non-Caucasian: 54.5
% MA criterion: 80
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 0
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Pill counts
Theory: Cognitive-behavioral Theory, motivational interviewing
Interventionist: NA
Content: Motivational interviewing, behavior modification, decisional balance activities, thought restructuring, self-re-evaluation, barriers management, problem solving, goal setting, habit linking, rewards, diary to self-monitor MA, relapse prevention, improve patient communication with provider, drug education, social support
Target: MA and additional health behaviors
Delivery: Written materials
Dose: 1 contact
0.405
Ramirez Canada-Garcia & Cote, 201243 N: 44
Mean meds: NA
Health: 100% HIV
% female: 9.8
% non-Caucasian: NA
% MA criterion: NA
Randomized: Yes
Allocation concealed: Yes
Blinded: NA
% Attrition: 13.7
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: Social Cognitive Theory, Persuasion Theory
Interventionist: Nurse
Content: Self-efficacy enhancement, thought restructuring, problem solving, goal setting, improve patient communication with provider, social support, drug education, side effects management
Target: MA only
Delivery: Face-to-face, written materials
Dose: 4 sessions, 60 min each
−0.411
Remien et al., 200544 United States N: 115
Mean meds: NA
Health: 100% HIV
% female: 46
% non-Caucasian: 86
% MA criterion: 80
Randomized: Yes
Allocation concealed: Yes
Blinded: Yes
% Attrition: 0
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: Ewart’s Social Action Theory
Interventionist: Advanced practice nurse
Content: Cognitive modification, behavior modification, disease/drug education, barriers management, problem solving, social support
Target: MA and additional health behaviors
Delivery: Face-to-face
Dose: 4 sessions, 45–60 min each
0.184
Rosen et al., 200745 United States N: 56
Mean meds: NA
Health: 100% HIV
% female: 41
% non-Caucasian: 59
% MA criterion: 80
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 0
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: NA
Interventionist: Person other than HCP
Content: Monitoring MA by device with feedback about MA, payment for taking medications, cues/prompts
Target: MA and additional health behaviors
Delivery: Face-to-face
Dose: 16 sessions
0.507
Ruppar, 201046 United States N: 15
Mean meds: NA
Health: 100% HTN
% female: 73
% non-Caucasian: 33
% MA criterion: 85
Randomized: Yes
Allocation concealed: Yes
Blinded: No
% Attrition: 0
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: Self-Regulation Theory
Interventionist: Advanced practice nurse
Content: Disease/drug education, habit linking, BP self-monitoring, MA self-monitoring using electronic device, feedback about BP and MA, goal setting, pill boxes, special medication labels
Target: MA only
Delivery: Face-to-face
Dose: 5 sessions
1.039
Russell et al., 201047 United States N: 13
Mean meds: NA
Health: 100% kidney transplant
% female: 53
% non-Caucasian: NA
% MA criterion: 85
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 13.3
ITT: No
Comparison: Attention control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: Continuous System Improvement
Interventionist: Advanced practice nurse
Content: Personal system change; habit linking, goal setting, problem solving, monitoring MA by device with feedback about MA
Target: MA only
Delivery: Face-to-face, written materials
Dose: 6 sessions
1.3682
Safren et al., 200150 United States N: 53
Mean meds: NA
Health: 100% HIV
% female: 13
% non-Caucasian: 49
% MA criterion: 100
Randomized: No
Allocation concealed: NA
Blinded: NA
% Attrition: 5.4
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: Cognitive-behavioral Theory, motivational interviewing, Problem solving Theory
Interventionist: Person other than HCP
Content: Motivational interviewing, cognitive and behavior modification, disease/drug education, habit linking, cues/prompts, pill boxes improved patient communication and shared decision-making with health care provider, problem solving, thought restructuring, guided imagery, side effects management
Target: MA only
Delivery: Face-to-face, telephone, videotape
Dose: 2 sessions
0.060
Safren et al., 200348 United States N: 44
Mean meds: NA
Health: 100% HIV
% female: 20
% non-Caucasian: 47
% MA criterion: 90
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: NA
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: NA
Interventionist: NA
Content: Pager system for medication taking reminders
Target: MA only
Delivery: Telephone
Dose: NA
0.470
Sorensen et al., 200751 United States N: 66
Mean meds: NA
Health: 100% HIV
% female: 41
% non-Caucasian: 44
% MA criterion: 80
Randomized: Yes
Allocation concealed: Yes
Blinded: NA
% Attrition: 0
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: Behavioral Modification
Interventionist: Person other than HCP
Content: Behavior modification, payment for taking medication
Target: MA only
Delivery: NA
Dose: 24 contacts
0.485
Stewart et al., 200852 Australia N: 343
Mean meds: NA
Health: 100% HTN, 73.5% cardiovascular disease, including stroke, cardiac disease, 35.5% diabetes, 34.5% depression
% female: 48.9
% non-Caucasian: NA
% MA criterion: NA
Randomized: No
Allocation concealed: Yes
Blinded: NA
% Attrition: 13.2
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: Motivational interviewing
Interventionist: Pharmacist
Content: Motivational interviewing, medication review for appropriate prescription, self-monitor of symptoms/signs with feedback, drug education, pill boxes, cues/prompts to refill prescriptions, health care provider improved skills to enhance patient MA, health care integration
Target: MA and additional health behaviors
Delivery: Face-to-face, telephone, text messages, mail, written materials
Dose: NA
0.122
Taylor, et al., 200353 United States N: 69
Mean meds: 6
Health: 76.8% HTN, 55% hyperlipidemia, 42% diabetes, 14.5% anti-coagulant therapy, 12% osteoarthritis
% female: 68.1
% non-Caucasian: NA
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 14.8
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: NA
Interventionist: Pharmacist
Content: Disease/drug education, medication review and reduction in number of prescriptions to increase MA, problem solving, pill boxes, teach skills related to administering medications and self-monitoring of signs
Target: MA only
Delivery: Face-to-face, written materials
Dose: Number of sessions determined by frequency of clinic visits, 20 min each
1.223
Van Servellen et al., 200555 United States N: 69
Mean meds: NA
Health: 100% HIV
% female: 9.9
% non-Caucasian: 100
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 18.8
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: NA
Interventionist: Advanced practice nurse, person other than HCP
Content: Disease/drug education, increase health literacy, motivational interviewing, empower patients to improve communication with providers; problem solving, barriers management, stress management, social support
Target: MA and additional health behaviors
Delivery: Face-to-face, telephone, videotape, written materials
Dose: NA
0.074
Vervloet et al., 201256 Netherlands N: 104
Mean meds: NA
Health: 100% Type 2 diabetes
% female: 45.2
% non-Caucasian: NA
% MA criterion: 80
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 12.6
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: NA
Interventionist: Automated delivery
Content: Real-time electronic monitoring of medication-taking with transmission of short text-message reminders
Target: MA only
Delivery: Text messages
Dose: NA
0.544
Villeneuve et al., 201057 Canada N: 225
Mean meds: NA
Health: 100% hyperlipidemia, 64% HTN, 43% diabetes
% female: 38
% non-Caucasian: NA
% MA criterion: NA
Randomized: No
Allocation concealed: NA
Blinded: NA
% Attrition: 0
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Prescription refills
Theory: NA
Interventionist: Physician, pharmacist
Content: Organizational improvement; improved integration of health care, teach provider skills to improve communication with patient and promote MA, patient/provider concordance, drug education, feedback to patients on symptoms/signs, goal setting
Target: MA and additional health behaviors
Delivery: Face-to-face, written materials
Dose: NA
0.105
Wall, et al., 199558 United States N: 25
Mean meds: 3.0
Health: 100% HIV
% female: 48
% non-Caucasian: 68
% MA criterion: NA
Randomized: Yes
Allocation concealed: NA
Blinded: NA
% Attrition: 7.4
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Electronic event monitoring device
Theory: NA
Interventionist: Registered nurse
Content: Self-administration program with directly observed therapy, distance-to-pharmacy barriers management, charting MA as a clinical parameter, feedback about MA and clinical signs
Target: MA only
Delivery: Face-to-face
Dose: 40 contacts
0.175
Watakakasol, 201059 United States N: 42
Mean meds: NA
Health: 100% HIV
% female: 40.5
% non-Caucasian: 7.1
% MA criterion: 95
Randomized: Yes
Allocation concealed: Yes
Blinded: Yes
% Attrition: 0
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Patient medication administration diary
Theory: Motivational interviewing, Transtheoretical Stages of Change Model
Interventionist: Person other than HCP
Content: Motivational interviewing, decisional balance and decision-making activities related to MA, problem solving, rewards, intervention targeted to subject’s stage of change
Target: MA only
Delivery: Telephone
Dose: 1 session, 60 min
−0.199
Wu et al., 200660 Hong Kong, China N: 442
Mean meds: 6
Health: various unspecified chronic illnesses
% female: 51
% non-Caucasian: NA
% MA criterion: 80
Randomized: Yes
Allocation concealed: Yes
Blinded: No
% Attrition: 0
ITT: Yes
Comparison: True control
Tx fidelity: NA
MA Measure: Self-report
Theory: NA
Interventionist: Pharmacist
Content: Drug education, telephone conversations to encourage MA and self-monitoring of symptoms/side effects
Target: MA and additional health behaviors
Delivery: Telephone
Dose: 7 contacts, 5–10 min each
0.607
Zuckerman et al., 200461 United States N: 1,675
Mean meds: NA
Health: 100% coronary artery disease
% female: NA
% non-Caucasian: NA
% MA criterion: NA
Randomized: No
Allocation concealed: NA
Blinded: NA
% Attrition: NA
ITT: No
Comparison: True control
Tx fidelity: NA
MA Measure: Prescription refills
Theory: NA
Interventionist: NA
Content: Teach physicians skills to enhance patient MA
Target: MA only
Delivery: Written materials mailed to patients’ physicians
Dose: NA
0.134

Abbreviations and definitions: BP, blood pressure; HCP, health care provider; HTN, hypertension; MA, medication adherence; NA, not addressed; N, total number of subjects at outcome assessment ; % MA criterion, maximum adherence level for eligibility; Blinded, data collectors masked to group assignment; ITT, intention-to-treat analysis; Tx fidelity, treatment fidelity; Target, intervention focused on MA exclusively or MA plus other health behaviors; Effect size, standardized mean difference effect size.